209 related articles for article (PubMed ID: 15189367)
21. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
Wimalawansa SJ
Am J Med; 1998 Mar; 104(3):219-26. PubMed ID: 9552083
[TBL] [Abstract][Full Text] [Related]
22. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis.
Menon KV; Angulo P; Boe GM; Lindor KD
Am J Gastroenterol; 2003 Apr; 98(4):889-92. PubMed ID: 12738473
[TBL] [Abstract][Full Text] [Related]
24. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
Heikkinen AM; Niskanen LK; Salmi JA; Koulu M; Pesonen U; Uusitupa MI; Komulainen MH; Tuppurainen MT; Kröger H; Jurvelin J; Saarikoski S
Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
Dane C; Dane B; Cetin A; Erginbas M
Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study on combination of multiple regimens in treatment of osteoporosis in perimenopause and postmenopausal women].
Guan YT; Cai LL; Ding HX; Chen GD; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):571-4. PubMed ID: 21029610
[TBL] [Abstract][Full Text] [Related]
27. Management of osteoporosis in primary biliary cirrhosis.
Wolfhagen FH; van Buuren HR; Vleggaar FP; Schalm SW
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):629-41. PubMed ID: 10976019
[TBL] [Abstract][Full Text] [Related]
28. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
29. Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
Sawada K; Morishige K; Ohmichi M; Nishio Y; Yamamoto T; Hayakawa J; Mabuchi S; Isobe A; Sasaki H; Sakata M; Tasaka K; Murata Y
Maturitas; 2007 Apr; 56(4):343-9. PubMed ID: 17010541
[TBL] [Abstract][Full Text] [Related]
30. Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis.
Verma A; Maxwell JD; Ang L; Davis T; Hodges S; Northfield TC; Zaidi M; Pazianas M
Osteoporos Int; 2002 Aug; 13(8):677-82. PubMed ID: 12181628
[TBL] [Abstract][Full Text] [Related]
31. Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin.
Boone RH; Cheung AM; Girlan LM; Heathcote EJ
Dig Dis Sci; 2006 Jun; 51(6):1103-12. PubMed ID: 16865577
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study.
Komulainen M; Tuppurainen MT; Kröger H; Heikkinen AM; Puntila E; Alhava E; Honkanen R; Saarikoski S
Osteoporos Int; 1997; 7(2):126-32. PubMed ID: 9166392
[TBL] [Abstract][Full Text] [Related]
33. Osteoporosis prevention clinical study program.
Delmas P; Gimona A
Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S39-45. PubMed ID: 8732473
[TBL] [Abstract][Full Text] [Related]
34. Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages.
Evans SF; Davie MW
Clin Endocrinol (Oxf); 1996 Jan; 44(1):79-84. PubMed ID: 8706298
[TBL] [Abstract][Full Text] [Related]
35. Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis.
Grey AB; Cundy TF; Reid IR
Clin Endocrinol (Oxf); 1994 May; 40(5):671-7. PubMed ID: 8013147
[TBL] [Abstract][Full Text] [Related]
36. Additive effect of alfacalcidol on bone mineral density of the lumbar spine in Taiwanese postmenopausal women treated with hormone replacement therapy and calcium supplementation: a randomized 2-year study.
Chen M; Chow SN
Clin Endocrinol (Oxf); 2001 Aug; 55(2):253-8. PubMed ID: 11531934
[TBL] [Abstract][Full Text] [Related]
37. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement.
Popat VB; Calis KA; Kalantaridou SN; Vanderhoof VH; Koziol D; Troendle JF; Reynolds JC; Nelson LM
J Clin Endocrinol Metab; 2014 Sep; 99(9):3418-26. PubMed ID: 24905063
[TBL] [Abstract][Full Text] [Related]
38. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?
Heikkinen AM; Kröger H; Niskanen L; Komulainen MH; Ryynänen M; Parviainen MT; Tuppurainen MT; Honkanen R; Saarikoski S
Maturitas; 2000 Jan; 34(1):33-41. PubMed ID: 10687880
[TBL] [Abstract][Full Text] [Related]
39. Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study.
Tiraş MB; Noyan V; Yildiz A; Yildirim M; Daya S
Hum Reprod; 2000 Oct; 15(10):2087-92. PubMed ID: 11006178
[TBL] [Abstract][Full Text] [Related]
40. Osteoporosis in primary biliary cirrhosis revisited.
Newton J; Francis R; Prince M; James O; Bassendine M; Rawlings D; Jones D
Gut; 2001 Aug; 49(2):282-7. PubMed ID: 11454807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
